These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36828396)

  • 1. Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease-A Systematic Review.
    Jabbari B; Comtesse SM
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-oriented approach to botulinum toxin use.
    Jankovic J
    Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in the management of parkinsonian disorders.
    Grippe T; Chen R
    Toxicon; 2023 Aug; 232():107209. PubMed ID: 37429465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin treatment in parkinsonism.
    Anandan C; Jankovic J
    J Neurol Sci; 2024 Jan; 456():122810. PubMed ID: 38056063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Botulinum Toxin Injection Protocols for Parkinson Tremor and Essential Tremor - the Yale Technique and Sensor-Based Kinematics Procedure for Safe and Effective Treatment.
    Mittal SO; Jog M; Lee J; Jabbari B
    Tremor Other Hyperkinet Mov (N Y); 2020 Dec; 10():61. PubMed ID: 33442486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study.
    Giladi N; Gurevich T; Shabtai H; Paleacu D; Simon ES
    J Neurol; 2001 Jul; 248(7):572-6. PubMed ID: 11517998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for motor disorders.
    Safarpour D; Jabbari B
    Handb Clin Neurol; 2023; 196():539-555. PubMed ID: 37620089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Onabotulinum Toxin A on Gait in Parkinson's Disease Patients with Foot Dystonia.
    Huang P; Li YY; Park JE; Huang P; Xiao Q; Wang Y; Chen S; Chen SD; Liu J; Wu YW
    Can J Neurol Sci; 2022 Jan; 49(1):123-128. PubMed ID: 33685541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal limb dystonia and tremor: Clinical update.
    Murgai AA; Jog M
    Toxicon; 2020 Mar; 176():10-14. PubMed ID: 31965968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
    Sheffield JK; Jankovic J
    Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of therapeutic benefits of botulinum toxin for foot dystonia associated with Parkinson's disease.
    Ni P; Xu YY; Wang LN; Cao JQ; Luo WF; Zhang QL; Li X; Zhou XP; Liu J
    Toxicon; 2024 Feb; 238():107587. PubMed ID: 38142904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin treatment of freezing of gait in Parkinson's disease patients as reflected in functional magnetic resonance imaging of leg movement.
    Vastik M; Hok P; Hlustik P; Otruba P; Tüdös Z; Kanovsky P
    Neuro Endocrinol Lett; 2016; 37(2):147-53. PubMed ID: 27179579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Botulinum Toxin for Treatment of the Dystonias.
    Berardelli A; Conte A
    Handb Exp Pharmacol; 2021; 263():107-126. PubMed ID: 31820178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin for foot dystonia in patients with Parkinson's disease having deep brain stimulation: A case series and a pilot study.
    Gupta AD; Visvanathan R
    J Rehabil Med; 2016 Jun; 48(6):559-62. PubMed ID: 27122065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A treatment of four cases of Wilson disease with lower limb dystonia: A prospective study.
    Cao Z; Rao R; Wu T; Chen S; Xing S; Han Y
    Toxicon; 2023 Jan; 221():106959. PubMed ID: 36343759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin injections do not improve freezing of gait in Parkinson disease.
    Wieler M; Camicioli R; Jones CA; Martin WR
    Neurology; 2005 Aug; 65(4):626-8. PubMed ID: 16116132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Focal or Segmental Dystonia Resistant to Botulinum Toxin: How Do You Treat Patients in Whom Botulinum Toxin Treatment Has No Effect?].
    Nomura T
    Brain Nerve; 2022 May; 74(5):581-587. PubMed ID: 35589651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin for treatment of the focal dystonia].
    Nakamura Y
    Rinsho Shinkeigaku; 2017 Jul; 57(7):367-372. PubMed ID: 28652522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.